Sarepta Therapeutics Receives Complete Response Letter from the FDA for Golodirsen New Drug Application Read more
EMA Validates Marketing Application for Filgotinib for the Treatment of Rheumatoid Arthritis Read more
Registration is now open for the Pre-filled Syringes and Injectable devices Conference 2020 Read more
Syapse Announces Research Collaboration with the FDA Focused on the Regulatory Use of Real-World Evidence Read more